The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma

BACKGROUND: The outcome of patients who progress on front-line immune-based combination regimens (IC) including immune checkpoint inhibitors (CPI) and receive subsequent systemic therapy is unknown. METHODS: Retrospective analysis of consecutive patients with clear-cell mRCC who progressed on one of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Barata, Pedro Coelho, De Liano, Alfonso Gomez, Mendiratta, Prateek, Crolley, Valerie, Szabados, Bernadett, Morrison, Laura, Wood, Laura, Allman, Kimberly, Tyler, Allison, Martin, Allison, Gilligan, Timothy, Grivas, Petros, Ornstein, Moshe, Garcia, Jorge A., Powles, Thomas, Rini, Brian I.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6048048/
https://ncbi.nlm.nih.gov/pubmed/29795307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0104-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados